The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Trial and Error
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,487
Serruys, P. W., Morice, M.-C., Kappetein, A. P., Colombo, A., Holmes, D. R., Mack, M. J., Ståhle, E., Feldman, T. E., van den Brand, M., Bass, E. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804626 · Cited by 4,331
Moses, J. W., Leon, M. B., Popma, J. J., Fitzgerald, P. J., Holmes, D. R., O'Shaughnessy, C., Caputo, R. P., Kereiakes, D. J., Williams, D. O., Teirstein, P. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035071 · Cited by 4,224
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
Bhatt, D. L., Fox, K. A. A., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., Cacoub, P., Cohen, E. A., Creager, M. A., Easton, J. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060989 · Cited by 2,837
Cannon, C. P., Weintraub, W. S., Demopoulos, L. A., Vicari, R., Frey, M. J., Lakkis, N., Neumann, F.-J., Robertson, D. H., DeLucca, P. T., DiBattiste, P. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442501 · Cited by 2,103
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
Sterne, J. A. C. (2001) · BMJ · doi:10.1136/bmj.322.7280.226 · Cited by 1,466
Statistics in Medicine — Reporting of Subgroup Analyses in Clinical Trials
Wang, R., Lagakos, S. W., Ware, J. H., Hunter, D. J., & Drazen, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr077003 · Cited by 1,445
(1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382102 · Cited by 1,321
Toward Evidence-Based Medical Statistics. 1: The P Value Fallacy
Goodman, S. N. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-12-199906150-00008 · Cited by 1,185
Subgroup analysis and other (mis)uses of baseline data in clinical trials
Assmann, S. F., Pocock, S. J., Enos, L. E., & Kasten, L. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02039-0 · Cited by 1,167
The way I see it: House officers need formal career development
Connor, A. (2002) · BMJ · doi:10.1136/bmj.324.7336.s71 · Cited by 1,143
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02336-7 · Cited by 1,116
Yusuf, S. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470010097038 · Cited by 1,014
Boersma, E., Harrington, R. A., Moliterno, D. J., White, H., Théroux, P., Van de Werf, F., de Torbal, A., Armstrong, P. W., Wallentin, L. C., Wilcox, R. G., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07442-1 · Cited by 991
Subgroup analysis in randomised controlled trials: importance, indications, and interpretation
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17709-5 · Cited by 942
Braunwald, E. (2002) · Journal of the American College of Cardiology · Cited by 868
Bhatt, D. L., Flather, M. D., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., Cacoub, P., Cohen, E. A., Creager, M. A., Easton, J. D., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.025 · Cited by 805
Composite Outcomes in Randomized Trials: Greater Precision But With Greater Uncertainty?
Freemantle, N., Calvert, M., Wood, J., Eastaugh, J., & Griffin, C. (2003) · JAMA · doi:10.1001/jama.289.19.2554 · Cited by 783
Morrow, D. A. (2001) · JAMA · doi:10.1001/jama.286.19.2405 · Cited by 656
Early Invasive versus Selectively Invasive Management for Acute Coronary Syndromes
de Winter, R. J., Windhausen, F., Cornel, J. H., Dunselman, P. H. J. M., Janus, C. L., Bendermacher, P. E. F., Michels, H. R., Sanders, G. T., Tijssen, J. G. P., & Verheugt, F. W. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044259 · Cited by 535
The Analysis of Multiple Endpoints in Clinical Trials
Pocock, S. J., Geller, N. L., & Tsiatis, A. A. (1987) · Biometrics · doi:10.2307/2531989 · Cited by 524
The Challenge of Subgroup Analyses — Reporting without Distorting
Lagakos, S. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068070 · Cited by 504
Ferreira-González, I., Permanyer-Miralda, G., Domingo-Salvany, A., Busse, J. W., Heels-Ansdell, D., Montori, V. M., Akl, E. A., Bryant, D. M., Alonso-Coello, P., Alonso, J., et al. (2007) · BMJ · doi:10.1136/bmj.39136.682083.ae · Cited by 473
Validity of composite end points in clinical trials
Montori, V. M., Permanyer-Miralda, G., Ferreira-González, I., Busse, J. W., Pacheco-Huergo, V., Bryant, D., Alonso, J., Akl, E. A., Domingo-Salvany, A., Mills, E., et al. (2005) · BMJ · doi:10.1136/bmj.330.7491.594 · Cited by 442
The Problem With Composite End Points in Cardiovascular Studies
Kip, K. E., Hollabaugh, K., Marroquin, O. C., & Williams, D. O. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.034 · Cited by 348
Superiority, equivalence, and non-inferiority trials.
Lesaffre, E. M. E. H. (2008) · PubMed · Cited by 225
Ferreira-González, I., Permanyer-Miralda, G., Busse, J. W., Bryant, D. M., Montori, V. M., Alonso-Coello, P., Walter, S. D., & Guyatt, G. H. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.10.020 · Cited by 221
Modzelewski, M. (2009) · PubMed · Cited by 208
Placing Trials in Context Using Bayesian Analysis
Brophy, J. M. (1995) · JAMA · doi:10.1001/jama.1995.03520350053028 · Cited by 154
Sosnowski, C. (2008) · PubMed · Cited by 143
Subgroup analyses in therapeutic cardiovascular clinical trials: Are most of them misleading?
Hernández, A. V., Boersma, E., Murray, G. D., Habbema, J. D. F., & Steyerberg, E. W. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.020 · Cited by 131
Lessons Learned From Recent Cardiovascular Clinical Trials: Part II
DeMets, D. L., & Califf, R. M. (2002) · Circulation · doi:10.1161/01.cir.0000023220.26465.89 · Cited by 123
Diamond, G. A., & Kaul, S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.01.035 · Cited by 121
Self-citationComposite outcomes in cardiovascular research: a survey of randomized trials.
Lim, E., Brown, A., Helmy, A., Mussa, S., & Altman, D. G. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-9-200811040-00004 · Cited by 116
Clinical significance not statistical significance: a simple Bayesian alternative to p values.
Burton, P. R., Gurrin, L. C., & Campbell, M. J. (1998) · Journal of Epidemiology & Community Health · doi:10.1136/jech.52.5.318 · Cited by 112
Principles From Clinical Trials Relevant to Clinical Practice: Part I
Califf, R. M., & DeMets, D. L. (2002) · Circulation · doi:10.1161/01.cir.0000023260.78078.bb · Cited by 108
Lessons Learned From Recent Cardiovascular Clinical Trials: Part I
DeMets, D. L., & Califf, R. M. (2002) · Circulation · doi:10.1161/01.cir.0000023219.51483.66 · Cited by 104
Ledmyr, H., McMahon, A. D., Ehrenborg, E., Lithell, H., Packard, C. J., & Karpe, F. (2002) · Circulation · Cited by 72
The Charisma of Subgroups and the Subgroups of CHARISMA
Pfeffer, M. A., & Jarcho, J. A. (2006) · New England Journal of Medicine · doi:10.1056/nejme068061 · Cited by 69
Subgroups, treatment effects, and baseline risks: Some lessons from major cardiovascular trials
Parker, A. B., & Naylor, C. D. (2000) · American Heart Journal · doi:10.1067/mhj.2000.106610 · Cited by 57
Kaul, S., & Diamond, G. A. (2006) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2006.10.001 · Cited by 38
Self-citationStatistical Reasoning in Medicine
Moyé, L. A. (2006) · Springer eBooks · doi:10.1007/978-0-387-46212-7 · Cited by 21
Cited by
Mehta, S. R., Jolly, S. S., Cairns, J., Niemela, K., Rao, S. V., Cheema, A. N., Steg, P. G., Cantor, W. J., Džavík, V., Budaj, A., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.050 · Cited by 381
“Excellence R Us”: university research and the fetishisation of excellence
Moore, S., Neylon, C., Paul Eve, M., Paul O’Donnell, D., & Pattinson, D. (2017) · Palgrave Communications · doi:10.1057/palcomms.2016.105 · Cited by 264
Zannad, F., Garcia, A. A., Anker, S. D., Armstrong, P. W., Calvo, G., Cleland, J. G. F., Cohn, J. N., Dickstein, K., Domanski, M. J., Ekman, I., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft095 · Cited by 231
The European CRT Survey: 1 year (9–15 months) follow-up results
Bogale, N., Priori, S., Cleland, J. G. F., Brugada, J., Linde, C., Auricchio, A., van Veldhuisen, D. J., Limbourg, T., Gitt, A., Gras, D., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr158 · Cited by 98
Writing for publication in a medical journal
Steen, R. G. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.102988 · Cited by 9
Metadata
- Authors
- Kaul, S., & Diamond, G. A.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 55
- Issue
- 5
- Pages
- 415-427
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W57046154
- Cited by
- 269
- References
- 50
- FWCI
- 36.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.